Torpedo Therapeutics
High-precision, closed-loop neuromodulation devices
We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.
Active Founders
Ingrid van Welie, Founder
Ingrid van Welie, PhD, is the Founder and CEO of Torpedo Therapeutics. Ingrid is a neuroscientist and biophysicist and is focused on developing and commercializing new technologies for sensing and modulating the electrical properties of neurons in the brain.
